We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Polystyrene Nanoplastics Hitch-Hike the Gut–Brain Axis to Exacerbate Parkinson’s Pathology
AI summary Read the abstract
Scientists found that polystyrene nanoplastics can travel from the gut to the brain along nerve pathways and worsen Parkinson's disease in mice. The nanoplastics accelerated the clumping of alpha-synuclein, a protein central to Parkinson's, which triggered brain inflammation, damaged mitochondria, and impaired the cellular cleanup system. Mice exposed to both nanoplastics and the disease protein showed progressive physical and motor decline resembling Parkinson's symptoms.
The neurological implications of micro- and nanoplastic exposure have recently come under scrutiny due to the environmental prevalence of these synthetic materials. Parkinson's disease (PD) is a major neurological disorder clinically characterized by intracellular Lewy-body inclusions and dopaminergic neuronal death. These pathological hallmarks of PD, according to Braak's hypothesis, are mediated by the afferent propagation of α synuclein (αS) via the enteric nervous system, or the so-called gut-brain axis. Here we first examined the effect of enteric exposure to polystyrene nanoplastics on the peripheral and central pathogenesis of A53T, a representative αS mutant. Specifically, the polystyrene nanoplastics accelerated the amyloid aggregation of A53T αS, which subsequently elevated the in vitro production of glial activation biomarkers, cytokines, and reactive oxygen species and compromised mitochondrial and lysosomal membrane integrity, further shifting cellular metabolite profiles in association with PD pathophysiology. In vivo, coadministration of the polystyrene nanoplastics and A53T αS facilitated their synergistic gut-to-brain transmission in mice, leading to progressive impairment of physical and motor skills in resemblance to characteristic PD symptoms. This study provides insights into the response and vulnerability of Parkinson's gut-brain axis to polystyrene nanoplastics.
More Papers Like This
Dysfunctional digestive tract highlights the metabolic hallmarks of nanoplastic-exacerbated Parkinson’s pathology
AI summary Read the abstract
Researchers found that oral exposure to polystyrene nanoplastics worsened Parkinson's disease progression in genetically predisposed mice by damaging the gut lining, disrupting the gut microbiome, and altering hundreds of metabolites through the gut-liver axis. The findings suggest that everyday nanoplastic ingestion could accelerate neurodegeneration in people already at risk for Parkinson's disease.
Anionic nanoplastic contaminants promote Parkinson’s disease–associated α-synuclein aggregation
AI summary Read the abstract
Researchers discovered that nanoplastics can enter brain cells and accelerate the clumping of alpha-synuclein, a protein whose buildup is the hallmark of Parkinson's disease. In mice, nanoplastics worsened the spread of this protein pathology across brain regions, including the area that controls movement, suggesting a potential link between nanoplastic pollution and Parkinson's disease risk.
Micro- and nanoplastics as environmental modifiers of neuroimmune dysfunction in Parkinson's disease
AI summary Read the abstract
This review paper looks at how tiny plastic particles from pollution—called micro- and nanoplastics—might build up in the brain and trigger inflammation and immune system problems linked to Parkinson's disease. While scientists haven't yet proven that these plastics actually cause Parkinson's in humans, the research so far suggests they could act as a stress factor that makes the brain more vulnerable to damage, especially through effects on brain cells and the gut-brain connection. This matters because it highlights another reason to think about reducing everyday plastic exposure, even though more direct human studies are needed before drawing firm conclusions.
Brain single-nucleus transcriptomics highlights that polystyrene nanoplastics potentially induce Parkinson’s disease-like neurodegeneration by causing energy metabolism disorders in mice
AI summary Read the abstract
In a mouse study, oral exposure to polystyrene nanoplastics caused brain changes resembling Parkinson's disease, including loss of dopamine-producing neurons and movement problems. Advanced single-cell brain analysis revealed that the nanoplastics disrupted energy production in brain cells, particularly in the brain regions most affected by Parkinson's disease. This research raises the alarming possibility that chronic nanoplastic exposure through food and water could contribute to neurodegenerative diseases.
Cerebral to Systemic Representations of Alzheimer’s Pathogenesis Stimulated by Polystyrene Nanoplastics
AI summary Read the abstract
Researchers found that environmentally realistic levels of polystyrene nanoplastics worsened Alzheimer's disease symptoms in mice, triggering brain inflammation, neuron death, and cognitive decline. The nanoplastics also disrupted metabolism and caused organ damage beyond the brain, including liver and kidney effects. This study provides some of the first evidence that nanoplastic exposure could accelerate brain diseases like Alzheimer's, especially as nanoplastics have been found in human brain tissue.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.